Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease
Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease
Recruiting · NCT06497361 · Registry updated 2024-07-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Immunoglobulin G4-Related Disease, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Recruiting | Early phase 1 | 2024-07-11 | NCT06497361 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shenzhen Pregene Biopharma Co., Ltd. | 7 |
| Tongji Hospital | 276 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tongji Hospital | Wuhan | China | 49 |